Katrina M. Nolan

675 total citations
18 papers, 463 citations indexed

About

Katrina M. Nolan is a scholar working on Epidemiology, Virology and Infectious Diseases. According to data from OpenAlex, Katrina M. Nolan has authored 18 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 5 papers in Virology and 4 papers in Infectious Diseases. Recurrent topics in Katrina M. Nolan's work include Pneumonia and Respiratory Infections (11 papers), Respiratory viral infections research (10 papers) and HIV Research and Treatment (5 papers). Katrina M. Nolan is often cited by papers focused on Pneumonia and Respiratory Infections (11 papers), Respiratory viral infections research (10 papers) and HIV Research and Treatment (5 papers). Katrina M. Nolan collaborates with scholars based in United States, Israel and Canada. Katrina M. Nolan's co-authors include James A. Hoxie, Andrea P. O. Jordan, Luwy Musey, George J. Leslie, Beth Haggarty, Josephine Romano, Joseph M. Antonello, Hari Pujar, Chitrananda Abeygunawardana and Tina Green and has published in prestigious journals such as Journal of Virology, PLoS Pathogens and Vaccine.

In The Last Decade

Katrina M. Nolan

17 papers receiving 454 citations

Peers

Countries citing papers authored by Katrina M. Nolan

Since Specialization

Citations

This map shows the geographic impact of Katrina M. Nolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrina M. Nolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrina M. Nolan more than expected).

Fields of papers citing papers by Katrina M. Nolan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrina M. Nolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrina M. Nolan. The network helps show where Katrina M. Nolan may publish in the future.

Co-authorship network of co-authors of Katrina M. Nolan

This figure shows the co-authorship network connecting the top 25 collaborators of Katrina M. Nolan. A scholar is included among the top collaborators of Katrina M. Nolan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrina M. Nolan. Katrina M. Nolan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	The impact of pneumococcal vaccination and nasopharyngeal colonization on the performance of a serotype-specific urine antigen detection (SSUAD) assay 2025 ·Vaccine ·(unknown), Ulrike K. Buchwald, Laura L. Hammitt, Jason J. LeBlanc, (unknown), (unknown), (unknown), Robert Weatherholtz, Luwy Musey, Tulin Shekar, Stephanie Cooper, (unknown), (unknown), J.D. Cronk, (unknown), (unknown), Katrina M. Nolan	0
2	Cross reactivity within pneumococcal serogroups 6 and 15 following adult vaccination with pneumococcal conjugate vaccine V116 2025 ·Communications Medicine ·Jianing Li, Heather Platt, Wen‐Yu Hu, Weifeng Xu, Timothy J. Chapman, Katrina M. Nolan, Jonathan Hartzel, Ulrike K. Buchwald	1
3	Establishing a new human pneumococcal standard reference serum, MPRSS-01 2025 ·mSphere ·Joseph M. Antonello, (unknown), Chitrananda Abeygunawardana, Juliana C. Malinverni, Gowrisankar Rajam, Tina Green, (unknown), (unknown), (unknown), C Bonhomme, Katrina M. Nolan	1
4	The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C 2023 ·Human Vaccines & Immunotherapeutics ·(unknown), Katrina M. Nolan, Robert L. Burton, Tulin Shekar, (unknown), Natalie Banniettis, Luwy Musey, Ulrike K. Buchwald	6
5	Development and Validation of Two Optimized Multiplexed Serologic Assays for the 9-Valent Human Papillomavirus Vaccine Types 2023 ·mSphere ·Katrina M. Nolan, Brent L. Seaton, Joseph M. Antonello, Yuhua Zhang, (unknown), (unknown), Leonard J. Rubinstein, (unknown), (unknown), Alain Luxembourg, Sheri Dubey	6
6	Development and Validation of a Sensitive and Robust Multiplex Antigen Capture Assay to Quantify Streptococcus pneumoniae Serotype-Specific Capsular Polysaccharides in Urine 2022 ·mSphere ·(unknown), Yuhua Zhang, Joseph M. Antonello, Rebecca J. Grant-Klein, (unknown), (unknown), Huy P. Pham, Stephanie Cooper, (unknown), (unknown), Mathias W. Pletz, (unknown), (unknown), Leonard J. Rubinstein, Katrina M. Nolan	11
7	Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU) 2021 ·Human Vaccines & Immunotherapeutics ·Randall Severance, Howard Schwartz, Ron Dagan, (unknown), Jianing Li, Alison Pedley, Jonathan Hartzel, Tina M. Sterling, Katrina M. Nolan, Gretchen Tamms, Luwy Musey, Ulrike K. Buchwald, (unknown)	16
8	Raising the Bar 2020 ·Journal for Nurses in Professional Development ·(unknown), Katrina M. Nolan, (unknown)	1
9	Enhanced Antipneumococcal Antibody Electrochemiluminescence Assay: Validation and Bridging to the WHO Reference ELISA 2020 ·Bioanalysis ·Katrina M. Nolan, Yuhua Zhang, Joseph M. Antonello, (unknown), C Bonhomme, (unknown), Tina Green, (unknown), David Goldblatt, (unknown)	36
10	A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants 2020 ·The Pediatric Infectious Disease Journal ·Heather Platt, David Greenberg, Bruce Tapiéro, (unknown), Nicola P. Klein, David Hurley, Tulin Shekar, Jianing Li, (unknown), Shu‐Chih Su, Katrina M. Nolan, Camilo J. Acosta, Richard McFetridge, Kara Bickham, Luwy Musey, (unknown)	43
11	Optimization and Validation of a Microcolony Multiplexed Opsonophagocytic Killing Assay for 15 Pneumococcal Serotypes 2020 ·Bioanalysis ·Katrina M. Nolan, (unknown), (unknown), Tina Green, Joseph M. Antonello, (unknown)	31
12	Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults 2019 ·Human Vaccines & Immunotherapeutics ·(unknown), Jeffrey B. Rosen, James T. Peterson, Angela Williams‐Diaz, (unknown), Tina M. Sterling, Camilo J. Acosta, Katrina M. Nolan, Jianing Li, Alison Pedley, (unknown), Chitrananda Abeygunawardana, (unknown), William J. Smith, Hari Pujar, Luwy Musey	83
13	A dose ranging study of 2 different formulations of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants 2019 ·Human Vaccines & Immunotherapeutics ·Randall G. Rupp, David Hurley, (unknown), (unknown), Katrina M. Nolan, Richard McFetridge, (unknown), Chitrananda Abeygunawardana, Michael A. Winters, Hari Pujar, (unknown), Luwy Musey	53
14	Characterization of a Human Immunodeficiency Virus Type 1 V3 Deletion Mutation That Confers Resistance to CCR5 Inhibitors and the Ability To Use Aplaviroc-Bound Receptor 2009 ·Journal of Virology ·Katrina M. Nolan, Gregory Q. Del Prete, Andrea P. O. Jordan, Beth Haggarty, Josephine Romano, George J. Leslie, James A. Hoxie	24
15	V3 Loop Truncations in HIV-1 Envelope Impart Resistance to Coreceptor Inhibitors and Enhanced Sensitivity to Neutralizing Antibodies 2007 ·PLoS Pathogens ·(unknown), (unknown), Beth Haggarty, (unknown), Katrina M. Nolan, (unknown), Josephine Romano, Andrea P. O. Jordan, George J. Leslie, Eric G. Meissner, Lishan Su, James A. Hoxie, Robert W. Doms	65
16	Live attenuated Listeria monocytogenes expressing HIV Gag: Immunogenicity in rhesus monkeys 2007 ·Vaccine ·Shisong Jiang, Robert A. Rasmussen, Katrina M. Nolan, Fred R. Frankel, Judy Lieberman, Harold M. McClure, Kristina M. Williams, Uma S. Babu, Richard B. Raybourne, Elizabeth Strobert, Ruth M. Ruprecht	28
17	Effects of Partial Deletions within the Human Immunodeficiency Virus Type 1 V3 Loop on Coreceptor Tropism and Sensitivity to Entry Inhibitors 2007 ·Journal of Virology ·Katrina M. Nolan, Andrea P. O. Jordan, James A. Hoxie	35
18	Replication-Competent Variants of Human Immunodeficiency Virus Type 2 Lacking the V3 Loop Exhibit Resistance to Chemokine Receptor Antagonists 2007 ·Journal of Virology ·George Lin, Andrea Bertolotti‐Ciarlet, Beth Haggarty, Josephine Romano, Katrina M. Nolan, George J. Leslie, Andrea P. O. Jordan, Chih-chin Huang, Peter D. Kwong, Robert W. Doms, James A. Hoxie	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact